Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Marpai, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
10/06/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
10/06/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/23/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
08/17/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Marpai, Inc.",
"Agreement”) is entered into as of August 16, 2023 , between Lutz Finger, an individual and Marpai, Inc., a Delaware corporation ."
08/03/2023 8-K Quarterly results
Docs: "New York, August 3, 2023—Marpai, Inc. , a technology company transforming the $22 billion Third-Party Administrator market supporting self-funded employer health plans, today reported financial results for the second quarter ended June 30, 2023. The Company’s consolidated results of operations include the results of operations of Marpai and its wholly owned subsidiaries, Marpai Health, Inc. and Marpai Administrators, LLC for all periods presented, and the results of Maestro Health, LLC since its acquisition on November 1, 2022."
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/27/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
07/17/2023 8-K Quarterly results
06/30/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Marpai Confirms Revenue Guidance for Q2 2023 of"
06/29/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ...
Docs: "CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF MARPAI, INC. Marpai, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware , does hereby certify that: FIRST: The name of the Corporation is Marpai, Inc. SECOND: This certificate of amendment amends the provisions of the Corporation’s certificate of incorporation, as amended , last amended and filed with the Secretary of State of the State of Delaware on September 2, 2021. THIRD: Article IV of the Certificate of Incorporation is hereby amending Section 3 to effectuate the Reverse Split as follow: “Upon the filing of this Certificate of Amendment with the Secretary of State of the State of Delaware , each four outstanding shares of Common Stock outstanding imme...",
"Marpai Announces Reverse Stock Split"
06/05/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/01/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/01/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Marpai Launches Marpai Connect Platform to Predict and Help Modify Risk in Healthcare"
05/26/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
05/10/2023 8-K Quarterly results
Docs: "New York, May 10, 2023—Marpai, Inc. , a technology company transforming the $22 billion Third-Party Administrator market supporting self-funded employer health plans, today reported financial results for the first quarter ended March 31, 2023. The Company’s consolidated results of operations include the results of operations of Marpai and its wholly owned subsidiaries, Marpai Health, Inc. and Marpai Administrators, LLC for all periods presented, and the results of Maestro Health, LLC since its acquisition on November 1, 2022."
04/26/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/19/2023 8-K Quarterly results
04/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/17/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/29/2023 8-K Quarterly results
03/29/2023 10-K Annual Report for the period ended December 31, 2022
02/07/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Marpai Hires Gonen Antebi as Chief Operating Officer Seasoned healthtech leader with a track of profitable growth to lead Company’s TPA businesses NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Marpai, Inc. , an AI-technology company transforming self-funded employer health plans, has hired Gonen Antebi as its Chief Operating Officer. Most recently, Mr. Antebi has served as the Chief Executive Officer of Nuvem Health , where he created the teams, technology and processes that drove a small start-up into an industry leader in just seven years. Prior to Nuvem, Mr. Antebi gained vast experience in healthcare data and third-party administration serving as Chief Operating Officer at ArroHealth and as Chief Executive Officer of MedSave USA, Inc. “Gonen is the best operator I have met in my career..."
02/02/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
02/01/2023 8-K Quarterly results
01/31/2023 EFFECT Form EFFECT - Notice of Effectiveness:
01/20/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
01/13/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
01/10/2023 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits  Interactive Data
Docs: "Maestro Health, LLC. and Subsidiaries Consolidated Financial Statements Years Ended December 31, 2021 and 2020 Mazars USA LLP is an independent member firm of Mazars Group. Maestro Health, LLC. and Subsidiaries",
"Maestro Health, LLC. and Subsidiaries Consolidated Financial Statements Nine Months Ended September 30, 2022 Maestro Health, LLC. and Subsidiaries",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction The following unaudited pro forma condensed combined financial information is based on the historical consolidated financial statements of Marpai, Inc. and Maestro Health, LLC , after giving effect to Marpai’s acquisition of Maestro. The notes to the unaudited pro forma condensed combined financial information describe the reclassifications and transaction accounting adjustments to the financial information presented. Hereinafter, Marpai and Maestro are collectively referred to as the “Companies,” and the Companies, subsequent to the Acquisition, are referred to herein as the “Combined Company.” The following unaudited pro forma condensed combined financial information has been prepared in..."
01/05/2023 4 Bibring Yoram (See Remarks) has filed a Form 4 on Marpai, Inc.
Txns: Granted 200,000 options to buy @ $0.79, valued at $158k
12/09/2022 4 Finger Lutz (See Remarks) has filed a Form 4 on Marpai, Inc.
Txns: Disposed/sold 140,614 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy